Visual cycle modulation in neurovascular retinopathy

Experimental Eye Research

Volumn 91, Issue 2, 2010, Pages 153-161

  Akula, James D ^a,b   Hansen, Ronald M ^a,b   Tzekov, Radouil ^c   Favazza, Tara L ^a   Vyhovsky, Tanya C ^a   Benador, Ilan Y ^a   Mocko, Julie A ^a   McGee, David ^c   Kubota, Ryo ^c   Fulton, Anne B ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Acucela Inc   (United States)

Author keywords

Electroretinography; Metabolism; N retinylacetamide; Photoreceptors; Retinoid; Retinopathy; Visual cycle

Indexed keywords

OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DARK ADAPTATION; ELECTRORETINOGRAPHY; EYE FUNDUS; NONHUMAN; PHOTORECEPTOR; PHOTOTRANSDUCTION; PRIORITY JOURNAL; RAT; RETINA ROD; RETROLENTAL FIBROPLASIA; STIMULUS RESPONSE; VISUAL ACUITY; VISUAL CYCLE MODULATION; VISUAL STIMULATION;

ACETAMIDES; ANIMALS; ANIMALS, NEWBORN; DARK ADAPTATION; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; HUMANS; INFANT, NEWBORN; INJECTIONS, INTRAPERITONEAL; OXYGEN; PHOTIC STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RETINAL NEOVASCULARIZATION; RETINAL PIGMENT EPITHELIUM; RETINAL ROD PHOTORECEPTOR CELLS; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; VISION, OCULAR;

EID: 77954958266     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.04.008     Document Type: Article

References (69)

1. Akula J.D., Favazza T.L., Mocko J.A., Benador I.Y., Asturias A.L., Kleinman M.S., Hansen R.M., Fulton A.B. The anatomy of the rat eye with oxygen-induced retinopathy. Doc. Ophthalmol 2009.
2. Akula J.D., Hansen R.M., Martinez-Perez M.E., Fulton A.B. Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2007, 48:4351-4359.
3. Akula J.D., Mocko J.A., Benador I.Y., Hansen R.M., Favazza T.L., Vyhovsky T.C., Fulton A.B. The neurovascular relation in oxygen-induced retinopathy. Mol. Vis. 2008, 14:2499-2508.
4. Alpern M., Fulton A.B., Baker B.N. " Self-screening" of rhodopsin in rod outer segments. Vision Res. 1987, 27:1459-1470.
5. Arden G.B. The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br. J. Ophthalmol. 2001, 85:366-370.
6. Arden G.B., Sidman R.L., Arap W., Schlingemann R.O. Spare the rod and spoil the eye. Br. J. Ophthalmol. 2005, 89:764-769.
7. Arden G.B., Wolf J.E., Tsang Y. Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis. Vision Res. 1998, 38:1723-1729.
8. Barnett J.M., Yanni S.E., Penn J.S. The development of the rat model of retinopathy of prematurity. Doc. Ophthalmol 2009.
9. Baylor D.A., Lamb T.D., Yau K.W. Responses of retinal rods to single photons. J. Physiol. 1979, 288:613-634.
10. Berkowitz B.A., Roberts R., Oleske D.A., Chang M., Schafer S., Bissig D., Gradianu M. Quantitative mapping of ion channel regulation by visual cycle activity in rodent photoreceptors in vivo. Invest. Ophthalmol. Vis. Sci. 2009, 50:1880-1885.
11. Berkowitz B.A., Roberts R., Penn J.S., Gradianu M. High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2007, 48:4733-4740.
12. Cringle S.J., Yu D.Y., Alder V.A. Intraretinal oxygen tension in the rat eye. Graefes Arch. Clin. Exp. Ophthalmol. 1991, 229:574-577.
13. -/- mice reduces retinal hypoxia and hypoxia-regulated gene expression. Invest. Ophthalmol. Vis. Sci. 2006, 47:5553-5560.
14. de Gooyer T.E., Stevenson K.A., Humphries P., Simpson D.A., Gardiner T.A., Stitt A.W. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47:5561-5568.
15. Dembinska O., Rojas L.M., Chemtob S., Lachapelle P. Evidence for a brief period of enhanced oxygen susceptibility in the rat model of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 2002, 43:2481-2490.
16. Dodt E., Echte K. Dark and light adaptation in pigmented and white rat as measured by electroretinogram threshold. J. Neurophysiol. 1961, 24:427-445.
17. Dorfman A., Dembinska O., Chemtob S., Lachapelle P. Early manifestations of postnatal hyperoxia on the retinal structure and function of the neonatal rat. Invest. Ophthalmol. Vis. Sci. 2008, 49:458-466.
18. ETROP Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch. Ophthalmol. 2003, 121:1684-1694.
19. Fulton A.B., Akula J.D., Mocko J.A., Hansen R.M., Benador I.Y., Beck S.C., Fahl E., Seeliger M.W., Moskowitz A., Harris M.E. Retinal degenerative and hypoxic ischemic disease. Doc. Ophthalmol. 2009, 118:55-61.
20. Fulton A.B., Baker B.N. The relation of retinal sensitivity and rhodopsin in developing rat retina. Invest. Ophthalmol. Vis. Sci. 1984, 25:647-651.
21. Fulton A.B., Dodge J., Hansen R.M., Schremser J.L., Williams T.P. The quantity of rhodopsin in young human eyes. Curr. Eye Res. 1991, 10:977-982.
22. Fulton A.B., Dodge J., Hansen R.M., Williams T.P. The rhodopsin content of human eyes. Invest. Ophthalmol. Vis. Sci. 1999, 40:1878-1883.
23. Fulton A.B., Hansen R.M. Electroretinogram responses and refractive errors in patients with a history of retinopathy prematurity. Doc. Ophthalmol. 1995, 91:87-100.
24. Fulton A.B., Hansen R.M., Findl O. The development of the rod photoresponse from dark-adapted rats. Invest. Ophthalmol. Vis. Sci. 1995, 36:1038-1045.
25. Fulton A.B., Hansen R.M., Moskowitz A., Akula J.D. The neurovascular retina in retinopathy of prematurity. Prog. Retin Eye Res 2009.
26. Fulton A.B., Hansen R.M., Roberto K., Penn J.S. Persistent dysfunction in a rat model of ROP. Invest. Ophthalmol. Vis. Sci. 1998, 39:S820.
27. Fulton A.B., Reynaud X., Hansen R.M., Lemere C.A., Parker C., Williams T.P. Rod photoreceptors in infant rats with a history of oxygen exposure. Invest. Ophthalmol. Vis. Sci. 1999, 40:168-174.
28. Gelman R., Martinez-Perez M.E., Vanderveen D.K., Moskowitz A., Fulton A.B. Diagnosis of plus disease in retinopathy of prematurity using retinal image multiscale analysis. Invest. Ophthalmol. Vis. Sci. 2005, 46:4734-4738.
29. Golczak M., Kuksa V., Maeda T., Moise A.R., Palczewski K. Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8162-8167.
30. Good W.V. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans. Am. Ophthalmol. Soc. 2004, 102:233-248. discussion 248-250.
31. Hagins W.A., Ross P.D., Tate R.L., Yoshikami S. Transduction heats in retinal rods: tests of the role of cGMP by pyroelectric calorimetry. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:1224-1228.
32. Hansen R.M., Eklund S.E., Benador I.Y., Mocko J.A., Akula J.D., Liu Y., Martinez-Perez M.E., Fulton A.B. Retinal degeneration in children: dark adapted visual threshold and arteriolar diameter. Vis. Res. 2008, 48:325-331.
33. Hartnett M.E., Martiniuk D., Byfield G., Geisen P., Zeng G., Bautch V.L. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest. Ophthalmol. Vis. Sci. 2008, 49:3107-3114.
34. Hood D.C., Birch D.G. A computational model of the amplitude and implicit time of the b-wave of the human ERG. Vis. Neurosci. 1992, 8:107-126.
35. Howes K.A., Pennesi M.E., Sokal I., Church-Kopish J., Schmidt B., Margolis D., Frederick J.M., Rieke F., Palczewski K., Wu S.M., Detwiler P.B., Baehr W. GCAP1 rescues rod photoreceptor response in GCAP1/GCAP2 knockout mice. EMBO J. 2002, 21:1545-1554.
36. Hughes A. A schematic eye for the rat. Vision Res. 1979, 19:569-588.
37. Kuksa V., Imanishi Y., Batten M., Palczewski K., Moise A.R. Retinoid cycle in the vertebrate retina: experimental approaches and mechanisms of isomerization. Vision Res. 2003, 43:2959-2981.
38. Lahdenranta J., Pasqualini R., Schlingemann R.O., Hagedorn M., Stallcup W.B., Bucana C.D., Sidman R.L., Arap W. An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10368-10373.
39. Lamb T.D., Pugh E.N. A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J. Physiol. 1992, 449:719-758.
40. Liu K., Akula J.D., Falk C., Hansen R.M., Fulton A.B. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2006, 47:2639-2647.
41. Lutty G.A., Chan-Ling T., Phelps D.L., Adamis A.P., Berns K.I., Chan C.K., Cole C.H., D'Amore P.A., Das A., Deng W.T., Dobson V., Flynn J.T., Friedlander M., Fulton A., Good W.V., Grant M.B., Hansen R., Hauswirth W.W., Hardy R.J., Hinton D.R., Hughes S., McLeod D.S., Palmer E.A., Patz A., Penn J.S., Raisler B.J., Repka M.X., Saint-Geniez M., Shaw L.C., Shima D.T., Smith B.T., Smith L.E., Tahija S.G., Tasman W., Trese M.T. Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Mol. Vis. 2006, 12:532-580.
42. Lyubarsky A.L., Pugh E.N. Recovery phase of the murine rod photoresponse reconstructed from electroretinographic recordings. J. Neurosci 1996, 16:564-571.
43. 2+. J. Gen. Physiol. 1996, 107:19-34.
44. Martinez-Perez M.E., Hughes A.D., Stanton A.V., Thom S.A., Chapman N., Bharath A.A., Parker K.H. Retinal vascular tree morphology: a semi-automatic quantification. IEEE Trans. Biomed. Eng. 2002, 49:912-917.
45. Martinez-Perez M.E., Hughes A.D., Thom S.A., Bharath A.A., Parker K.H. Segmentation of blood vessels from red-free and fluorescein retinal images. Med. Image Anal. 2007, 11:47-61.
46. Matthews H.R., Fain G.L. The effect of light on outer segment calcium in salamander rods. J. Physiol. 2003, 552:763-776.
47. McBee J.K., Palczewski K., Baehr W., Pepperberg D.R. Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina. Prog. Retin. Eye Res. 2001, 20:469-529.
48. Messias A., Zrenner E., Tzekov R., McGee D., Peters T., Wilhelm B., Baryluk A., Kubota R., Gekeler F. Single doses of all-trans-N-retinylacetamide slow down the ERG amplitude recovery after bleaching in rats. Doc. Ophthalmol. 2010, 120:165-174.
49. Moiseyev G., Chen Y., Takahashi Y., Wu B.X., Ma J.X. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:12413-12418.
50. Palmer E.A., Flynn J.T., Hardy R.J., Phelps D.L., Phillips C.L., Schaffer D.B., Tung B. Incidence and early course of retinopathy of prematurity. The cryotherapy for retinopathy of prematurity cooperative group. Ophthalmology 1991, 98:1628-1640.
51. Pe'er J., Shweiki D., Itin A., Hemo I., Gnessin H., Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995, 72:638-645.
52. Penn J.S., Henry M.M., Tolman B.L. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr. Res. 1994, 36:724-731.
53. 2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest. Ophthalmol. Vis. Sci. 1995, 36:2063-2070.
54. Perlman I. Kinetics of bleaching and regeneration of rhodopsin in abnormal (RCS) and normal albino rats in vivo. J. Physiol. 1978, 278:141-159.
55. Provis J.M., Leech J., Diaz C.M., Penfold P.L., Stone J., Keshet E. Development of the human retinal vasculature: cellular relations and VEGF expression. Exp. Eye Res. 1997, 65:555-568.
56. Pugh E.N., Lamb T.D. Amplification and kinetics of the activation steps in phototransduction. Biochim. Biophys. Acta 1993, 1141:111-149.
57. Rando R.R. The biochemistry of the visual cycle. Chem. Rev. 2001, 101:1881-1896.
58. Reiser M.A., Williams T.P., Pugh E.N. The effect of light history on the aspartate-isolated fast-PIII responses of the albino rat retina. Invest. Ophthalmol. Vis. Sci. 1996, 37:221-229.
59. Reynaud X., Dorey C.K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest. Ophthalmol. Vis. Sci. 1994, 35:3169-3177.
60. Reynaud X., Hansen R.M., Fulton A.B. Effect of prior oxygen exposure on the electroretinographic responses of infant rats. Invest. Ophthalmol. Vis. Sci. 1995, 36:2071-2079.
61. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
62. Sieving P.A., Chaudhry P., Kondo M., Provenzano M., Wu D., Carlson T.J., Bush R.A., Thompson D.A. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. PNAS USA 2001, 94:1835-1840.
63. Steinberg R. Monitoring communications between photoreceptors and pigment epithelial cells: effects of " mild" systemic hypoxia. Invest. Ophthalmol. Vis. Sci. 1987, 28:1888-1903.
64. Travis G.H., Golczak M., Moise A.R., Palczewski K. Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. Annu. Rev. Pharmacol. Toxicol. 2007, 47:469-512.
65. Tsai T.I., Bui B.V., Vingrys A.J. Dimethyl sulphoxide dose-response on rat retinal function. Doc. Ophthalmol. 2009, 119:199-207.
66. Wellard J., Lee D., Valter K., Stone J. Photoreceptors in the rat retina are specifically vulnerable to both hypoxia and hyperoxia. Vis. Neurosci. 2005, 22:501-507.
67. Whitmore G.A. Prediction limits for a univariate normal observation. Am. Stat. 1986, 40:141-143.
68. Wyszecki G., Stiles W.S. Color Science: Concepts and Methods, Quantitative Data and Formulae 1982, Wiley, New York.
69. Young R.W. The renewal of photoreceptor cell outer segments. J. Cell Biol. 1967, 33:61-72.